戻る Agenda
S2 - Regulatory Updates and Implications for Clinical Development
Session Chair(s)
Ling Su, PhD
Research Fellow
Yeehong Business School, China
Speaker(s)
Mizukami Maki
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Clinical Compliance Inspector, Office of Clinical & Non-clinical Compliance II
Xiaoyuan Chen, MD
Tsinghua University, China
Professor
Jooyeon Jung, MPHARM, MS
Ministry of Food and Drug Safety, Korea, Republic of
Division director